CD4 and cryptococcosis: This demonstrates that in settings where ART is widely available and HIV-infected patients who have CD4 counts < 100 cells/μL are initiated on ART and are negative for serum cryptococcal antigen, the primary prophylaxis for cryptococcosis with fluconazole has no survival benefit and may not be necessary [87].